InnoMed Capital
Overview
InnoMed Capital is a venture capital firm based in Nanjing, China that invests in strategic emerging industries including semiconductors, integrated circuits, new generation information technology, intelligent manufacturing, military equipment, and biotechnology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eaglenos Sciences, Inc. | May 2023 | Series A | Lead |
| PolarisIC Microelectronics | Dec 2022 | Pre Seed | Co-investor |
| Nanjing Saint Medical Technology Co., Ltd. | Jul 2022 | Series A | Co-investor |
| Niuxin Semiconductor | Dec 2021 | Series B | Co-investor |
| Chengdu UnionBigData Technology Co., Ltd. | Jun 2021 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is InnoMed Capital based?
InnoMed Capital is headquartered in Nanjing, China.
When was InnoMed Capital founded?
InnoMed Capital was founded in 2018.
How many portfolio companies does InnoMed Capital have?
InnoMed Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in InnoMed Capital's portfolio?
Recent investments visible on Caplight include Eaglenos Sciences, Inc., PolarisIC Microelectronics, Nanjing Saint Medical Technology Co., Ltd., Niuxin Semiconductor, Chengdu UnionBigData Technology Co., Ltd..
What was InnoMed Capital's most recent investment?
InnoMed Capital's most recent investment on Caplight was in Eaglenos Sciences, Inc. in 2023.
What sectors does InnoMed Capital focus on?
InnoMed Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Frontier & Industrial Tech.
What company stages does InnoMed Capital focus on?
Stage focus information for InnoMed Capital is not publicly available.